<SEC-DOCUMENT>0001123292-24-000280.txt : 20240923
<SEC-HEADER>0001123292-24-000280.hdr.sgml : 20240923
<ACCEPTANCE-DATETIME>20240923094115
ACCESSION NUMBER:		0001123292-24-000280
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240923
DATE AS OF CHANGE:		20240923

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PORTAGE BIOTECH INC.
		CENTRAL INDEX KEY:			0001095435
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D8
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-40086
		FILM NUMBER:		241315011

	BUSINESS ADDRESS:	
		STREET 1:		CLARENCE THOMAS BUILDING
		STREET 2:		P.O. BOX 4649, ROAD TOWN
		CITY:			TORTOLA
		STATE:			D8
		ZIP:			VG1110
		BUSINESS PHONE:		416-737-7600

	MAIL ADDRESS:	
		STREET 1:		CLARENCE THOMAS BUILDING
		STREET 2:		P.O. BOX 4649, ROAD TOWN
		CITY:			TORTOLA
		STATE:			D8
		ZIP:			VG1110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BONTAN CORP INC
		DATE OF NAME CHANGE:	20030421

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DEALCHECK COM INC
		DATE OF NAME CHANGE:	19990921

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MINTZ STEVEN
		CENTRAL INDEX KEY:			0002008741
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O AGEX THERAPEUTICS, INC.,
		STREET 2:		1101 MARINA VILLAGE PARKWAY, SUITE 201
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94501
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0002008741</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>



</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0001095435</issuerCik>
<issuerName>Portage Biotech Inc.</issuerName>
<secFileNumber>001-40086</secFileNumber>
<issuerAddress>
<com:street1>Clarence Thomas Building</com:street1>
<com:street2>P.O. Box 4649</com:street2>
<com:city>Road Town, Tortola</com:city>
<com:stateOrCountry>D8</com:stateOrCountry>
<com:zipCode>VG1110</com:zipCode>
</issuerAddress>
<issuerContactPhone>203-221-7378</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Steven Mintz</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>Director</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>BMO Nesbitt Burns Inc.</name>
<address>
<com:street1>1 First Canadian Place</com:street1>
<com:street2>39th Floor, P.O. Box 150</com:street2>
<com:city>Toronto</com:city>
<com:stateOrCountry>A6</com:stateOrCountry>
<com:zipCode>M5X 1H3</com:zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>6545</noOfUnitsSold>
<aggregateMarketValue>104456.79</aggregateMarketValue>
<noOfUnitsOutstanding>1048765</noOfUnitsOutstanding>
<approxSaleDate>09/18/2024</approxSaleDate>
<securitiesExchangeName>NASDAQ</securitiesExchangeName>
</securitiesInformation>
<securitiesInformation>
<securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>RBC Dominion Securities</name>
<address>
<com:street1>5140 Yonge Street</com:street1>
<com:street2>Suite 1100</com:street2>
<com:city>North York</com:city>
<com:stateOrCountry>A6</com:stateOrCountry>
<com:zipCode>M2N 6L7</com:zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>1032</noOfUnitsSold>
<aggregateMarketValue>16788.4</aggregateMarketValue>
<noOfUnitsOutstanding>1048765</noOfUnitsOutstanding>
<approxSaleDate>09/18/2024</approxSaleDate>
<securitiesExchangeName>NASDAQ</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
<acquiredDate>01/01/2019</acquiredDate>
<natureOfAcquisitionTransaction>Open Market Purchase</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Open Market</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>7577</amountOfSecuritiesAcquired>
<paymentDate>01/01/2019</paymentDate>
<natureOfPayment>Cash</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<remarks>Under securities to be sold, the date of acquisition and date of payment are various dates between January 2019 and February 2024.</remarks>
<noticeSignature>
<noticeDate>09/23/2024</noticeDate>
<signature>/s/ Steven Mintz</signature>
</noticeSignature>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
